SEC Form 4

FORM 4

[ ] Check this box if no longer
subject to Section 16. Form 4 or Form
5 obligations may continue.
See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility
Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940

OMB APPROVAL



OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden
hours per response. . . . . 0.5

1. Name and Address of Reporting Person*
Colen, Fred     


(Last)                      (First)                      (Middle)
One Boston Scientific Place


(Street)
Natick, MA     01760-1537


(City)                      (State)                      (Zip)
USA

2. Issuer Name and Ticker
    or Trading Symbol

Boston Scientific Corporation   (BSX)


3. I.R.S. Identification
    Number of Reporting
    Person, if an entity
    (voluntary)

4. Statement for
    (Month/Day/Year)

    December 9, 2002


5. If Amendment,
    Date of Original
    (Month/Year)

6. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

                        Director                           10% Owner
           X          Officer                             Other

Officer/Other
Description           Senior Vice President and Chief Technology Officer


7. Individual or Joint/Group
    Filing (Check Applicable Line)

X   Individual Filing
      Joint/Group Filing

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1. Title of Security
    (Instr. 3)

2. Transaction Date
    (Month/Day/Year)

3. Transaction
    Code
    and
    Voluntary
    Code
    (Instr. 8)



Code  |  V    

4. Securities Acquired (A) or Disposed (D) Of
    (Instr. 3, 4, and 5)





        Amount      |         A/D         |         Price          

5. Amount of
    Securities
    Beneficially
    Owned at
    End ofMonth

    (Instr. 3 and 4)

6. Owner-
    ship
    Form:
    Direct(D)
    or
    Indirect (I)

    (Instr. 4)

7. Nature of
     Indirect
     Beneficial
     Ownership

    (Instr. 4)

Common Stock



7,962

D









Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

(over)
SEC 1474 (3-99)


Colen, Fred - December 2002

Form 4 (continued)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
    (Instr. 3)

2. Conver-
    sion or
    Exercise
    Price of
    Deri-
    vative
    Security

3. Transaction
    Date

    (Month/
    Day/
    Year)

4. Transaction
    Code
    and
    Voluntary (V)
    Code
    (Instr.8)


Code | V    

5. Number of Derivative
    Securities Acquired (A)
    or Disposed (D) Of

    (Instr. 3,4 and 5)

6. Date Exercisable(DE) and
    Expiration Date(ED)
    (Month/Day/Year)






  (DE)     |     (ED)  

7. Title and Amount of
    Underlying Securities
    (Instr. 3 and 4)

8. Price
    of
    Derivative
    Security
    (Instr.5)

9. Number of
    Derivative
    Securities
    Beneficially
    Owned
    at End of
    Month
    (Instr.4)

10.
Owner-
ship
Form of
Deriv-
ative
Security:
Direct
(D)
or
Indirect
(I)

11. Nature of
      Indirect
      Beneficial
      Ownership
      (Instr.4)

Stock Option (Right to Buy)

$42.5100

12/09/2002

   A |     

    (A) 60,000

Varies (1) | 12/09/2012

Common Stock - 60,000


60,000

D


Stock Option (Right to Buy)

$35.7500




Varies (2) | 04/19/2009

Common Stock - 25,000


25,000

D


Stock Option (Right to Buy)

$28.3125




Varies (3) | 05/09/2010

Common Stock - 40,000


40,000

D


Stock Option (Right to Buy)

$17.0000




Varies (4) | 07/25/2010

Common Stock - 40,000


40,000

D


Stock Option (Right to Buy)

$12.2500




Varies (5) | 12/06/2010

Common Stock - 150,000


150,000

D


Stock Option (Right to Buy)

$15.8100




Varies (6) | 02/27/2011

Common Stock - 20,000


20,000

D


Stock Option (Right to Buy)

$17.9800




Varies (7) | 07/17/2011

Common Stock - 50,000


50,000

D


Stock Option (Right to Buy)

$25.0000




Varies (8) | 12/17/2011

Common Stock - 25,000


25,000

D













Explanation of Responses :

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
        See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note:   File three copies of this Form, one of which must be manually signed. If space is insufficient,
            See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not
required to respond unless the form displays a currently valid OMB number.

By: /s/ Lawrence J. Knopf, Attorney-in-fact
________________________________            12-10-2002    
** Signature of Reporting Person                         Date


Fred A. Colen

Page 2
SEC 1474 (3-99)


Colen, Fred - December 2002

Form 4 (continued)

FOOTNOTE Descriptions for Boston Scientific Corporation BSX

Form 4 - December 2002

Fred Colen
One Boston Scientific Place

Natick, MA 01760-1537


Explanation of responses:

(1)   Grant to the reporting person of an option to buy a specified number of shares of Common Stock exercisable 25% on December 9, 2003, 50% on December 9, 2004, 75% on December 9, 2005 and 100% on December 9, 2006, the anniversary date of the grant.
(2)   Grant to the reporting person of an option to buy a specified number of shares of Common Stock exercisable for 25% of the aggregate amount on April 19, 2000, 50% on April 19, 2001, 75% on April 19, 2002 and 100% on April 19, 2003, the anniversary date of the grant.
(3)   Grant to the reporting person of an option to buy a specified number of shares of Common Stock exercisable 25% on May 9, 2001, 50% on May 9, 2002, 75% on May 9, 2003 and 100% on May 9, 2004, the anniversary date of the grant.
(4)   Grant to the reporting person of an option to buy a specified number of shares of Common Stock exercisable 25% on July 25, 2001, 50% on July 25, 2002, 75% on July 25, 2003 and 100% on July 25, 2004, the anniversary date of the grant.
(5)   Grant to the reporting person of an option to buy a specified number of shares of Common Stock exercisable in approximately equal annual increments on December 6, 2001, 2002 and 2003, the anniversary date of this grant.
(6)   Grant to the reporting person of an option to purchase 20,000 shares of common stock of the Company exercisable in annual increments of 5,000 shares each on February 27, 2002, 2003, 2004 and 2005, the anniversary date of the grant.
(7)   Grant to the reporting person of an option to purchase 50,000 shares of common stock of the Company exercisable in annual increments of 12,500 shares each on July 17, 2002, 2003, 2004 and 2005, the anniversary date of the grant.
(8)   Grant to the reporting person of an option to buy a specified number of shares of Common Stock exercisable 25% on December 17, 2002, 50% on December 17, 2003, 75% on December 17, 2004 and 100% on December 17, 2005, the anniversary date of the grant.

Page 3